This course reviews the psychopharmacological strategies used for addressing a variety of mental health conditions including anxiety, depression, psychosis, impulsivity, and dementia. It will also address the effects of psychotropic drugs on patients or clients referred to mental health professionals for intellectual, neuropsychological and personality testing. Limitations of pharmacotherapy and its combinations with psychotherapy will be discussed.
Natural Sciences
Priority will be given to fourth-year students in the Specialist/Specialist Co-op programs and Major/Major Co-op programs in Mental Health Studies, as well as Major/Major Co-op programs in Psychology. Third-year students in these programs will be admitted as space permits. Students in a Specialist/Specialist Co-op Program in Psychology, Mental Health Studies or Neuroscience may take a maximum of 1.0 PSY/NRO D-level credits. Students in a Major/Major Co-op Program in Psychology, Mental Health Studies or Neuroscience may take a maximum of 0.5 PSY/NRO D-level credits per major. Students in the Minor Program in Psychology are not typically eligible for enrolment in PSY/NRO D-level courses. PSYD98Y3/NROD98Y3 are excluded from these limits. Please see this website for full information.
